Science and Enterprise

Tag: statistics

  • European Venture Deals Decline, Euro Volume Up

    Dow Jones VentureSource reports that venture capitalists put €916 million ($1.3 billion) into 198 deals for European companies in the third quarter in 2010, the lowest quarterly deal count for Europe since Dow Jones VentureSource began tracking the region ten years ago. Investment volume rose 6 percent from €866 million, despite the 25 percent drop…

  • Global R&D Spending Among Innovators Declines in 2009

    Total R&D spending among the world’s top spenders on innovation dropped in 2009 for the first time in the 13 years studied, according to the annual survey by management consulting firm Booz & Company. At the same time, most science-related companies, especially those in the health care industry, increased their R&D spending, with the pharmaceutical…

  • Chip Sales Continue Gains in September

    The Semiconductor Industry Association (SIA) reports today (1 November) that semiconductor companies booked worldwide sales of $26.5 billion in September 2010, a gain of 2.9 percent from August when sales were $25.8 billion. Sales for the third quarter of 2010 came to $79.4 billion, a 6.1 percent increase compared to the second quarter when sales…

  • U.S. Angel Investors Retreating from Start Up Deals

    While angel investors made more deals in the first half of 2010, compared to 2009, the total dollar volume invested dropped, as did the percentage of funding for seed and start up stage financing. Nonetheless, a majority of the deals involved science-related companies. These findings appear in a report published by the Center for Venture…

  • Worldwide Corporate R&D Drops, Pharma/Biotech Bucks Trend

    The European Commission’s 2010 “EU Industrial R&D Investment Scoreboard” shows that R&D investment by the world’s top 1,400 companies dropped by nearly 2 percent in the companies’ 2009 fiscal years, but with pharmaceutical/biotech companies and companies in Asian countries increasing their R&D spending. The worldwide economic recession, the report indicates, is taking its toll on…

  • Drug-Related Hospitalizations Double for Age 45+

    The number of hospital admissions for Americans age 45 and older from medication and drug-related conditions doubled between 1997 and 2008, according to a report released today by the Agency for Healthcare Research and Quality (AHRQ), in the U.S. Department of Health and Human Services. AHRQ defines medication and drug-related conditions to include effects of…

  • Venture Investing Down in Q3, Up for Year-to-Date

    In the third quarter of 2010, venture capital (VC) investors put $5.5 billion into 662 deals for U.S.-based companies, down 5 percent in dollars invested but a 2 percent increase in deals from the same period last year, according to Dow Jones VentureSource. Science-based companies were among those experiencing a downturn in VC investments. For…

  • NSF: Companies Investing in R&D Made More Innovations

    Preliminary data from the National Science Foundation’s 2008 Business R&D and Innovation Survey (BRDIS) show large differences in making innovations when companies in the U.S. with R&D activity are compared to those without any R&D activity. These data are based on respondents to the survey and represent an estimated 1.5 million for-profit companies, publicly or…

  • Advanced Statistical Analysis Enables Food Bacteria Detection

    Finding bacterial contamination in the food supply when the target contaminants are known is difficult enough, but finding food-borne bacteria that are not identified targets can seem like an overwhelming task. To attack this problem, researchers from Indiana University-Purdue University Indianapolis (IUPUI) and Purdue University in West Lafayette, Indiana have developed a new approach to…

  • Venture Funding Down for Science Startups in Q3 2010

    Venture capital (VC) funding in the U.S. for new companies overall, including science-based enterprises, dropped in the third quarter of 2010, according to a new MoneyTree Report from PricewaterhouseCoopers and the National Venture Capital Association based on data provided by Thomson Reuters. Overall, VC companies invested $4.8 billion in 780 deals in the third quarter…